These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 5813813)

  • 21. Evidence for an extrarenal action of chlorothiazide on serum potassium.
    Ezra D; Iaina A; Kapuler S; Almog S; Eshkol A; Gavendo S; Eliahou HE; Gafni J
    Miner Electrolyte Metab; 1982 Jun; 7(6):285-91. PubMed ID: 7169991
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Proximal tubular rejection of sodium by furosemide.
    Azer M; Kirkendall WM
    J Pharmacol Exp Ther; 1973 May; 185(2):235-44. PubMed ID: 4703819
    [No Abstract]   [Full Text] [Related]  

  • 23. Intravenously administered chlorothiazide in diagnostic evaluation of hypertensive disease.
    McGuffin WL; Gunnells JC
    Arch Intern Med; 1969 Feb; 123(2):124-30. PubMed ID: 5763614
    [No Abstract]   [Full Text] [Related]  

  • 24. Effect of chlorothiazide upon aldosterone excretion and sodium and potassium balance in essential hypertension.
    VENNING EH; DYRENFURTH I; DOSSETOR JB; BECK JC
    J Lab Clin Med; 1962 Jul; 60():79-85. PubMed ID: 13925333
    [No Abstract]   [Full Text] [Related]  

  • 25. Urinary excretion of sodium and potassium in relation to plasma aldosterone concentration.
    Adamson AR; Jamieson SW
    J Endocrinol; 1972 Jun; 53(3):425-31. PubMed ID: 4556970
    [No Abstract]   [Full Text] [Related]  

  • 26. Urinary kallikrein excretion after potassium adaptation in the rat.
    Obika LF
    Arch Int Physiol Biochim; 1987 Sep; 95(3):189-93. PubMed ID: 2446581
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Refractory ascites in cirrhosis: roles of volume expansion and plasma atrial natriuretic factor level elevation.
    Wong F; Tobe S; Legault L; Logan AG; Skorecki K; Blendis LM
    Hepatology; 1993 Sep; 18(3):519-28. PubMed ID: 8395457
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An attempt to reproduce experimentally the pattern of salt and water distribution of age in the young neurohypophysectomized adrenlectomized rat.
    Friedman SM; Gustafson B; Hamilton D; Friedman CL
    Can J Physiol Pharmacol; 1966 May; 44(3):429-33. PubMed ID: 5914361
    [No Abstract]   [Full Text] [Related]  

  • 29. Antimineralocorticoid action of progesterone in the rat: correlation of the effect on electrolyte excretion and interaction with renal mineralocorticoid receptors.
    Wambach G; Higgins JR
    Endocrinology; 1978 Jun; 102(6):1686-93. PubMed ID: 217633
    [No Abstract]   [Full Text] [Related]  

  • 30. Comparison of effects of d- and l-aldosterone on excretion of sodium and potassium by the adrenalectomized rat.
    LUETSCHER JA; DOWDY A; LEW W; CALLAGHAN AM
    Endocrinology; 1962 Mar; 70():445-7. PubMed ID: 14467234
    [No Abstract]   [Full Text] [Related]  

  • 31. Determination of antialdosterone activity in adrenalectomized dogs.
    Hershberger LG; Thompson CR
    Proc Soc Exp Biol Med; 1968 Oct; 129(1):24-6. PubMed ID: 5686523
    [No Abstract]   [Full Text] [Related]  

  • 32. Magnesium metabolism in potassium-depleted rats.
    Duarte CG
    Am J Physiol; 1978 Jun; 234(6):F466-71. PubMed ID: 665773
    [TBL] [Abstract][Full Text] [Related]  

  • 33. EFFECT OF POTASSIUM DEFICIENCY ON ACTION OF CHLOROTHIAZIDE IN THE RAT.
    MORRISON AB
    Am J Physiol; 1963 Sep; 205():494-8. PubMed ID: 14065900
    [No Abstract]   [Full Text] [Related]  

  • 34. 19-Oxoandrost-4-ene-3,17-dione amplifies the action of aldosterone.
    Sekihara H; Yazaki Y
    J Steroid Biochem Mol Biol; 1993 Jul; 46(1):69-72. PubMed ID: 8338792
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Amplification of the action of aldosterone by 5 alpha-dihydrocortisol.
    Adam WR; Funder JW; Mercer J; Ulick S
    Endocrinology; 1978 Aug; 103(2):465-71. PubMed ID: 744095
    [No Abstract]   [Full Text] [Related]  

  • 36. [The biological activity of tetrahydroaldosterone, tetrahydroaldosterone glucuronide and 18-aldosterone glucuronide in comparison with aldosterone].
    Möhring J; Möhring B; Siegenthaler W
    Klin Wochenschr; 1968 Jan; 46(1):22-4. PubMed ID: 5671702
    [No Abstract]   [Full Text] [Related]  

  • 37. 6 beta-hydroxy-4-androstene-3,17-dione: a potent amplifier of the kaliuretic action of aldosterone.
    Sekihara H; Ohsawa N; Kosaka K
    J Steroid Biochem; 1981 Apr; 14(4):327-9. PubMed ID: 7230795
    [No Abstract]   [Full Text] [Related]  

  • 38. Factors affecting the antidiuretic actions of the 18-monoacetate of (+)-aldosterone and of a substance secreted by eart muscle, in rats.
    Lockett MF
    J Pharm Pharmacol; 1973 Sep; 25(9):690-9. PubMed ID: 4148503
    [No Abstract]   [Full Text] [Related]  

  • 39. Aldosterone excretion in normal subjects depleted of sodium and potassium.
    JOHNSON BB; LIEBERMAN AH; MULROW PJ
    J Clin Invest; 1957 Jun; 36(6 Part 1):757-66. PubMed ID: 13439014
    [No Abstract]   [Full Text] [Related]  

  • 40. Amplification of the action of subthreshold doses of aldosterone by 19-hydroxyandrost-4-ene-3, 17-dione.
    Sekihara H; Ohsawa N; Kosaka K
    Biochem Biophys Res Commun; 1979 Apr; 87(3):827-35. PubMed ID: 454430
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.